Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I. [electronic resource]
Producer: 20160826Description: 111-6, 154 p. digitalISSN:- 1053-816X
- Adrenal Cortex Hormones -- therapeutic use
- Angiogenesis Inhibitors -- therapeutic use
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- epidemiology
- Bone Density Conservation Agents -- adverse effects
- Bone Neoplasms -- drug therapy
- Denosumab -- adverse effects
- Diphosphonates -- adverse effects
- Humans
- Imidazoles -- adverse effects
- Immunosuppressive Agents -- therapeutic use
- Incidence
- Jaw Diseases -- chemically induced
- Male
- Osteonecrosis -- chemically induced
- Prostatic Neoplasms -- pathology
- Risk Factors
- Stomatognathic Diseases -- epidemiology
- Tooth Extraction -- statistics & numerical data
- United Kingdom -- epidemiology
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.